Cardiogen-82
Drug Diagnostic Imaging
NDC 71920-091-01
General payments
$149,716
Research payments
$242,968
Through program year 2025, $149,716 in general payments and $242,968 in research payments were reported against Cardiogen-82 (Diagnostic Imaging).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $76,096 | 27 |
| 2024 | General | $9,247 | 13 |
| 2023 | General | $60,553 | 40 |
| 2023 | Research | $137,290 | 2 |
| 2022 | General | $3,820 | 41 |
| 2022 | Research | $105,678 | 2 |
Breakdown
The top 5 of 19 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
121 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.